<DOC>
	<DOC>NCT00400842</DOC>
	<brief_summary>This study is to verify the efficacy of 3.0 g/day of SA-001 in patients with pancreatic exocrine insufficiency caused by chronic pancreatitis in the non-compensatory stage or by pancreatectomy as compared with placebo under a double-blind design using the change in a coefficient of fat absorption as a primary endpoint.</brief_summary>
	<brief_title>A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis, Chronic</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<criteria>Inclusion Criteria Subjects with chronic pancreatitis in the noncompensatory stage or pancreatectomy Subjects whose CFA is 80% or less Subjects who are able to be hospitalized Exclusion Criteria Subjects who are judged to be difficult to have at least 40 g/day of fat intake during course of the study Subjects who have a known allergy to porcine protein and/or any component of digestive enzyme preparations Subjects who are in the acute phase of chronic pancreatitis Subjects with nonpancreatic malabsorption syndrome Subjects with acute pancreatitis or ileus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>SA-001</keyword>
	<keyword>Pancreatic Exocrine Insufficiency</keyword>
	<keyword>Pancreatectomy</keyword>
</DOC>